2012 Press Releases by Pancreatic Cancer Action Network

Home About the Pancreatic Cancer Action Network News / Press Center 2012 Press Releases by Pancreatic Cancer Action Network

December 21, 2012 -- The Recalcitrant Cancer Research Act Formerly Known as the Pancreatic Cancer Research & Education Act, Passes Congress

November 9, 2012 -- Study Shows Abraxane® Extends Survival for Patients with Advanced Pancreatic Cancer

November 1, 2012 -- The Pancreatic Cancer Action Network Calls on the Public to Take Action During National Pancreatic Cancer Awareness Month in November

September 19, 2012 -- Pancreatic Cancer Action Network Applauds House Passage of the Recalcitrant Cancer Research Act, Formerly Known as the Pancreatic Cancer Research & Education Act

September 11, 2012 -- New Report Projects Pancreatic Cancer to Become the Second Leading Cause of Cancer Death in the United States by 2020

August 29, 2012 -- Pancreatic Cancer Action Network -- AACR Grants Program Offers More Than $4 Million for Pancreatic Cancer Research

July 23, 2012 -- Pancreatic Cancer Action Network Responds To The Passing Of Sally Ride

June 26, 2012 -- Nearly 650 Turn Out for the Pancreatic Cancer Action Network’s Annual Advocacy Day

June 21, 2012 -- Pancreatic Cancer Research & Education Act Gains Momentum in Congress

May 25, 2012 -- The Pancreatic Cancer Research & Education Act (S.362) Reaches 50 Senate Co-Sponsors and Majority of Senate Help Committee

March 27, 2012 -- Pancreatic Cancer Action Network and AACR Award Research Grants Totaling More Than $3.4 Million

March 15, 2012 -- Pancreatic Cancer Action Network–AACR Pathway to Leadership Grants

January 10, 2012 -- The Pancreatic Cancer Action Network Welcomes Lynn Matrisian, PhD as Vice President of Scientific and Medical Affairs

January 5, 2012 -- Survival Rate for Pancreatic Cancer Remains Unchanged While Survival Improves for Other Leading Cancers

January 5, 2012 -- Green Bay Packer Jarius Wynn Joins the Fight Against Pancreatic Cancer

January 4, 2012 -- Clinical Trials are Key to Doubling the Survival Rate for Pancreatic Cancer